ÂÜÀòÂÒÂ×

Ronald Blum, Ph.D. has a diverse and extensive work experience in the field of marketing and strategy in the medical diagnostics industry. Ronald most recently served as the Chief Science Officer at Sinai Labs starting from May 2023. Prior to that, they held the role of Vice President of Marketing at MiraDx, Inc. since March 2022.

Before joining MiraDx, Inc., Ronald served as the Chief Marketing Officer at IncellDx from August 2019 to March 2022. Ronald also held the position of Commercialization & Technology Strategist at OncoTracker from July 2019 onwards.

Ronald has also gained experience as the CEO of Blum & Associates Consulting, LLC since 2017, where they provided strategic consulting services. In addition, they held executive positions at InSyncDx Solutions, Inc. as the Executive Vice President of Products and Strategy in July and August 2020.

Prior to their consulting work, Ronald held roles of increasing responsibility at RDL Reference Laboratory, Pathology, Inc., Exiqon Diagnostics, and Specialty Laboratories in the fields of commercialization, marketing, and research and development.

Overall, Ronald Blum's work experience demonstrates their expertise in marketing, strategic planning, and commercialization in the medical diagnostics industry.

Ronald Blum, Ph.D., obtained their Ph.D. in Biophysics from the University of California Berkeley.